# Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children

> **NCT00118807** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 1800 (—)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Amodiaquine plus artesunate (AQ/AS)
- **DRUG:** Sulfadoxine-pyrimethamine plus chloroquine (SP/CQ)
- **DRUG:** Sulfadoxine-pyrimethamine plus amodiaquine (SP/AQ)

## Key facts

- **NCT ID:** NCT00118807
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** 1800 (—)
- **Last updated:** 2006-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00118807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00118807, "Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00118807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*